SCHEMBL9201258

SCHEMBL9201258

O=C1c2ncccc2-c2n[nH]c3cccc1c23

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
MAPK8 P45983 2/20 0.67
MAPK9 P45984 2/20 0.67
MAPK10 P53779 2/20 0.67
ALDH1A1 P00352 2/20 0.67
TTK P33981 2/20 0.67
KDM4E B2RXH2 1/20 0.67
CDC7 O00311 1/20 0.67
PLK4 O00444 1/20 0.67
CHEK1 O14757 1/20 0.67
IKBKB O14920 1/20 0.67
RGS12 O14924 1/20 0.67
AURKA O14965 1/20 0.67
GAK O14976 1/20 0.67
NPC1 O15118 1/20 0.67
PDPK1 O15530 1/20 0.67
DAPK3 O43293 1/20 0.67
DYRK3 O43781 1/20 0.67
ROCK2 O75116 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796647 0.88 MEN1 (0.67) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL9115256 0.86 TTK (0.64) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL29941507 0.80 ALDH1A1 (1.00) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL29693577 0.80 ALDH1A1 (1.00) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL170980 0.80 ALDH1A1 (1.00) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL8866586 0.76 TTK (0.73) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL7817760 0.76 PIM1 (0.72) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL7810309 0.76 TTK (0.72) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL18216956 0.74 TTK (0.60) MEN1KMT2AMAPK8MAPK9MAPK10
SCHEMBL7946079 0.74 KDR (0.65) MEN1KMT2AMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP disclosed